Clinical Trial Update: dENdritic Cell Therapy Combined With SURgEry in Mesothelioma [Phase 1]

View source ↗

Summary

Phase 1 trial of dendritic cell therapy combined with surgery for malignant pleural mesothelioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Dendritic cell therapy

Snippet

Sponsor: Erasmus Medical Center | Conditions: Mesotheliomas Pleural | Phase 1 | Status: RECRUITING